Expression of resistin-like molecule beta in gastric cancer: Its relationship with clinicopathological parameters and prognosis

Virchows Archiv

Volumn 456, Issue 1, 2010, Pages 53-63

  Zheng, Liduan ^a   Weng, Mixia ^a   He, Jun ^a   Yang, Xiuping ^a   Jiang, Guosong ^a   Tong, Qiangsong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric cancer; Gene expression; Resistin like molecule beta

Indexed keywords

CELL PROTEIN; HEPARANASE; KI 67 ANTIGEN; RESISTIN LIKE MOLECULE BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER TISSUE; CARCINOGENESIS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTESTINE CARCINOMA; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; STOMACH CANCER; STOMACH MUCOSA; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; BARRETT ESOPHAGUS; CARCINOMA, PAPILLARY; CARCINOMA, SIGNET RING CELL; COLONIC NEOPLASMS; FEMALE; GASTRIC MUCOSA; GLUCURONIDASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 75049085232     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0861-4     Document Type: Article

References (41)

1. DM Parkin F Bray J Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. M Mitsuuchi Y Hinoda F Itoh, et al. 1999 Expression of MUC2 gene in gastric regenerative, metaplastic, and neoplastic epithelia J Clin Lab Anal 13 259 265 10.1002/(SICI)1098-2825(1999)13:6<259::AID-JCLA2>3.0.CO;2-2 1:CAS:528:DyaK1MXotFWqsL0%3D 10633292
3. HW Lee DH Yang HK Kim, et al. 2007 Expression of MUC2 in gastric carcinomas and background mucosae J Gastroenterol Hepatol 22 1336 1343 10.1111/j.1440-1746.2007.04939.x 1:CAS:528:DC%2BD2sXpvFSnsb0%3D 17559374 (Pubitemid 47224901)
4. T Yamachika JL Werther C Bodian, et al. 2002 Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma Clin Cancer Res 8 1092 1099 1:CAS:528:DC%2BD38XksVSqu70%3D 12006524
5. N Aksoy OF Akinci 2004 Mucin macromolecules in normal, adenomatous, and carcinomatous colon: evidence for the neotransformation Macromol Biosci 4 483 496 10.1002/mabi.200300099 1:CAS:528:DC%2BD2cXksVymsb4%3D 15468240 (Pubitemid 39249355)
6. M Babyatsky J Lin X Yio, et al. 2009 Trefoil factor-3 expression in human colon cancer liver metastasis Clin Exp Metastasis 26 143 151 10.1007/s10585-008-9224-9 1:CAS:528:DC%2BD1MXhvVKqtb8%3D 18979216
7. FE May BR Westley 1997 Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells J Pathol 182 404 413 10.1002/(SICI)1096-9896(199708)182:4<404::AID-PATH875>3.0. CO;2-0 1:CAS:528:DyaK2sXls1yitr0%3D 9306961 (Pubitemid 27317205)
8. FE May BR Westley 1997 Trefoil proteins: their role in normal and malignant cells J Pathol 183 4 7 10.1002/(SICI)1096-9896(199709)183:1<4::AID- PATH1099>3.0.CO;2-5 1:CAS:528:DyaK2sXmtVGjsr0%3D 9370940 (Pubitemid 27368519)
9. IP Garraway D Seligson J Said, et al. 2004 Trefoil factor 3 is overexpressed in human prostate cancer Prostate 61 209 214 10.1002/pros.20096 1:CAS:528:DC%2BD2cXpslOkt7s%3D 15368472 (Pubitemid 39350442)
10. MW Chan VY Chan WK Leung, et al. 2005 Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells Life Sci 76 2581 2592 10.1016/j.lfs.2004.11.014 1:CAS:528:DC%2BD2MXitlCntLk%3D 15769482 (Pubitemid 40354260)
11. CM Steppan EJ Brown CM Wright, et al. 2001 A family of tissue-specific resistin-like molecules PNAS 98 502 506 10.1073/pnas.98.2.502 1:CAS:528:DC%2BD3MXnslKhtg%3D%3D 11209052 (Pubitemid 32105071)
12. D Artis ML Wang SA Keilbaugh, et al. 2004 RELM{beta}/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract PNAS 101 13596 13600 10.1073/pnas.0404034101 1:CAS:528:DC%2BD2cXnvFehsrY%3D 15340149 (Pubitemid 39238448)
13. W He ML Wang HQ Jiang, et al. 2003 Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein Gastroenterology 125 1388 1397 10.1016/j.gastro.2003.07.009 1:CAS:528: DC%2BD3sXpslyru7w%3D 14598255 (Pubitemid 37409759)
14. RR Banerjee MA Lazar 2001 Dimerization of resistin and resistin-like molecules is determined by a single cysteine J Biol Chem 276 25970 25973 10.1074/jbc.M103109200 1:CAS:528:DC%2BD3MXlsVKgu7w%3D 11358969 (Pubitemid 37412803)
15. K Kinoshita DR Taupin H Itoh, et al. 2000 Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor Mol Cell Biol 20 4680 4690 10.1128/MCB.20.13.4680-4690.2000 1:CAS:528:DC%2BD3cXksVOjur0%3D 10848594 (Pubitemid 30396115)
16. LD Zheng QS Tong MX Weng, et al. 2009 Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance Dig Dis Sci 54 274 281 10.1007/s10620-008-0355-2 1:CAS:528:DC%2BD1MXhtlOqtLs%3D 18594973
17. Zheng L, Tong Q, Weng M et al (2010) Expression of resistin-like molecule beta in Barrett's esophagus: a novel biomarker for metaplastic epithelium. Dig Dis Sci 55. doi: 10.1007/s10620-009-0719-2
18. M Cassaro M Rugge O Gutierrez, et al. 2000 Topographic patterns of intestinal metaplasia and gastric cancer Am J Gastroenterol 95 1431 1438 10.1111/j.1572-0241.2000.02074.x 1:STN:280:DC%2BD3czltFSksQ%3D%3D 10894575
19. Fenoglio-Preiser C, Correa P, Guilford P et al (2000) WHO histological classification of gastric tumours. In: Hamilton SR AL, Hamilton SRAL (eds) World health organization classification of tumors. Pathology and genetics of tumors of the digestive system. IARC, Lyon, p 38
20. P Lauren 1965 The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31 49 1:STN:280: DyaF2M7isFenug%3D%3D 14320675
21. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN et al (2008) The neoplastic stomach. Gastrointestinal pathology: an atlas and text. Lippincott Williams & Wilkins, Philadelphia, pp 254-255
22. Sobin LH, Wittekind CH (1997) TNM classification of malignant tumors, ed 5. Wiley-Liss, New York, pp 59-62
23. M Nakajima T Irimura N Di Ferrante, et al. 1984 Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase J Biol Chem 259 2283 2290 1:CAS:528: DyaL2cXhslSmtLk%3D 6698965
24. A Munitz L Seidu ET Cole, et al. 2009 Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation J Immunol 182 2357 2363 10.4049/jimmunol.0803130 1:CAS:528:DC%2BD1MXhsFKrsL4%3D 19201890
25. MG Nair KJ Guild Y Du, et al. 2008 Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation J Immunol 181 4709 4715 1:CAS:528:DC%2BD1cXhtFarur3K 18802073
26. RB Krimi L Kotelevets L Dubuquoy, et al. 2009 Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice Inflamm Bowel Dis 14 931 941 10.1002/ibd.20420
27. SL Barnes A Vidrich ML Wang, et al. 2007 Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis J Immunol 179 7012 7020 1:CAS:528:DC%2BD2sXht1Crs7rJ 17982092
28. SP Hogan L Seidu C Blanchard, et al. 2006 Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility J Allergy Clin Immunol 118 257 268 10.1016/j.jaci.2006.04.039 1:CAS:528:DC%2BD28Xms1GltL0%3D 16815164 (Pubitemid 43946483)
29. MM Ribeiro JA Sarmento MA Sobrinho Simoes, et al. 1981 Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma Cancer 47 780 784 10.1002/1097-0142(19810215)47:4<780:: AID-CNCR2820470424>3.0.CO;2-G 1:STN:280:DyaL3M7osF2jtw%3D%3D 7226025 (Pubitemid 11135877)
30. C Furihata M Tatematsu K Miki, et al. 1984 Gastric- and intestinal-type properties of human gastric cancers transplanted into nude mice Cancer Res 44 727 733 1:STN:280:DyaL2c7gs1Ghsw%3D%3D 6692375
31. R Fiocca L Villani P Tenti, et al. 1988 Widespread expression of intestinal markers in gastric carcinoma: a light and electron microscopic study using BD-5 monoclonal antibody J Clin Pathol 41 178 187 10.1136/jcp.41.2.178 1:STN:280:DyaL1c7ntVSrsA%3D%3D 3350978
32. A Yoshikawa I Ki T Yamachika, et al. 1998 Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression Gastric Cancer 1 134 141 10.1007/s101200050007 11957057
33. T Yamachika K Inada Y Fujimitsu, et al. 1997 Intestinalization of gastric signet ring cell carcinomas with progression Virchows Arch 431 103 110 10.1007/s004280050075 1:STN:280:DyaK2svjvVWitA%3D%3D 9293891 (Pubitemid 27393840)
34. HC Zheng XH Li T Hara, et al. 2008 Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas Virchows Arch 452 525 534 10.1007/s00428-007-0572-7 1:CAS:528:DC%2BD1cXkvFyktrY%3D 18266006
35. M Ikeguchi K Fukuda K Yamaguchi, et al. 2003 Quantitative analysis of heparanase gene expression in esophageal squamous cell carcinoma Ann Surg Oncol 10 297 304 10.1245/ASO.2003.05.022 12679316 (Pubitemid 40486964)
36. AW Kim X Xu EF Hollinger, et al. 2003 Human heparanase-1 gene expression in pancreatic adenocarcinoma J Gastrointest Surg 6 167 172 10.1016/S1091- 255X(01)00087-7
37. RS Rivera H Nagatsuka CH Siar, et al. 2008 Heparanase and vascular endothelial growth factor expression in the progression of oral mucosal melanoma Oncol Rep 19 657 661 18288398
38. K Gohji M Okamoto S Kitazawa, et al. 2001 Heparanase protein and gene expression in bladder cancer J Urol 166 1286 1290 10.1016/S0022-5347(05)65754-0 1:CAS:528:DC%2BD3MXptVKks7Y%3D 11547059
39. S Stadlmann PL Moser J Pollheimer, et al. 2003 Heparanase-1 gene expression in normal, hyperplastic and neoplastic prostatic tissue Eur J Cancer 39 2229 2233 10.1016/S0959-8049(03)00457-X 1:CAS:528:DC%2BD3sXns1KlsLc%3D 14522383 (Pubitemid 37297750)
40. Z Wang H Xu L Jiang, et al. 2004 Positive association of heparanase expression with tumor invasion and lymphatic metastasis in gastric carcinoma Mod Pathol 18 205 211 10.1038/modpathol.3800282
41. M Takaoka Y Naomoto T Ohkawa, et al. 2003 Heparanase expression correlates with invasion and poor prognosis in gastric cancers Lab Invest 83 613 622 1:CAS:528:DC%2BD3sXjtlKjs74%3D 12746471